
    
      Prospective randomized controlled two arm multicenter trial to evaluate the efficacy and
      safety of Aquablation (AQUABEAM Robotic SystemÂ®, PROCEPT BioRobotics, Redwood City, CA, USA)
      compared to transurethral laser enucleation - the current reference standard of minimal
      invasive therapy for benign prostatic hyperplasia in large prostates (80-180ml).
    
  